INNATE IMMUNOTHERAPEUTICS LT
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for INNATE IMMUNOTHERAPEUTICS LT COM, CUSIP Q4934F101.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for INNATE IMMUNOTHERAPEUTICS LT COM, CUSIP Q4934F101.